当时阿糖苷酶（Ceredase）是通过复杂的技术，利用人体胎盘制成的，每年会花费每名病人15万美元的治疗费。
基于30个网页-相关网页
An earlier version of the drug, Ceredase, helped launch the lucrative market for high-priced orphan disease drugs, which is now one of the brightest spots in biotech.
FORBES: Pfizer Enters Market For Super-Expensive, Ultra-Rare Disease Drugs -- With A Price Cut
应用推荐
模块上移
模块下移
不移动